Table 6 Expression of FGFR1, MART1, TACC1 and WT1 proteins in human prostate cancer.
From: FGFR1 and WT1 are markers of human prostate cancer progression
Factors | benign | pT2 | pT3 | p-value |
|---|---|---|---|---|
No. of patients (%) | ||||
Age, years | 1 | |||
<=50 | 0 | 0 | 0 | |
>50 | 11 | 39 | 46 | |
Gleason | 0,057 | |||
5 | 0 | 3 | 1 | |
6 | 0 | 7 | 4 | |
7 | 0 | 25 | 28 | |
8 | 0 | 3 | 10 | |
9 | 0 | 0 | 4 | |
FGFR1 status | 0.001 | |||
negative | 9 | 27 | 17 | |
positive | 2 | 12 | 29 | |
MART1 status | 0.029 | |||
negative | 11 | 30 | 43 | |
positive | 0 | 9 | 3 | |
TACC1 status | 0.756 | |||
negative | 3 | 13 | 12 | |
positive | 8 | 26 | 34 | |
WT1 status | 0.008 | |||
negative | 9 | 24 | 17 | |
positive | 2 | 15 | 29 | |